Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O5ZK
|
|||
Drug Name |
PMID28454500-Compound-96
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE HAMNER INSTITUTES
|
|||
Structure |
Download2D MOL |
|||
Formula |
C8H10N2S
|
|||
Canonical SMILES |
CCC1=NC=CC(=C1)C(=S)N
|
|||
InChI |
1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)
|
|||
InChIKey |
AEOCXXJPGCBFJA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 536-33-4
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:4885
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nuclear factor erythroid 2-related factor 2 (Nrf2) | Target Info | Inhibitor | [1] |
Target's Patent Info | Nuclear factor erythroid 2-related factor 2 (Nrf2) | Target's Patent Info | [1] | |
KEGG Pathway | Protein processing in endoplasmic reticulum | |||
NetPath Pathway | IL5 Signaling Pathway | |||
WikiPathways | Oxidative Stress | |||
Transcriptional activation by NRF2 | ||||
NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | ||||
Aryl Hydrocarbon Receptor Pathway | ||||
Mesodermal Commitment Pathway | ||||
Aryl Hydrocarbon Receptor | ||||
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | ||||
Arylhydrocarbon receptor (AhR) signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):763-785. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.